BCL2 and neoplasm: The T16S H2a variant (H2aC1) is overexpressed in oestrogen dependent tumour cells and oestrogen receptor positive, but not negative, cells; the H2aC1 HAR domain is reported to recruit the oestrogen receptor to the promoter regions of BCL2 and c-MYC18,57.